JPH08507775A - 放出制御性のアルミニウム含有医薬製剤 - Google Patents

放出制御性のアルミニウム含有医薬製剤

Info

Publication number
JPH08507775A
JPH08507775A JP6520643A JP52064394A JPH08507775A JP H08507775 A JPH08507775 A JP H08507775A JP 6520643 A JP6520643 A JP 6520643A JP 52064394 A JP52064394 A JP 52064394A JP H08507775 A JPH08507775 A JP H08507775A
Authority
JP
Japan
Prior art keywords
aluminum
compound
phosphate
sodium
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6520643A
Other languages
English (en)
Japanese (ja)
Inventor
ラッシ，イストファン
プラチ，ヤノシュ
アンタル，イストファン
Original Assignee
ジネポス・アクチェンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9300744A external-priority patent/HUT70038A/hu
Application filed by ジネポス・アクチェンゲゼルシャフト filed Critical ジネポス・アクチェンゲゼルシャフト
Publication of JPH08507775A publication Critical patent/JPH08507775A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6520643A 1993-03-16 1994-03-16 放出制御性のアルミニウム含有医薬製剤 Pending JPH08507775A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9300744A HUT70038A (en) 1992-03-16 1993-03-16 2-oxoquinolines, pharmaceutical compositions containing them, and the process for preparing thereof
HU7404/93 1993-03-18
PCT/EP1994/000829 WO1994021268A1 (en) 1993-03-16 1994-03-16 Aluminium containing pharmaceutical preparation with controlled release

Publications (1)

Publication Number Publication Date
JPH08507775A true JPH08507775A (ja) 1996-08-20

Family

ID=10983353

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6520643A Pending JPH08507775A (ja) 1993-03-16 1994-03-16 放出制御性のアルミニウム含有医薬製剤

Country Status (7)

Country Link
EP (1) EP0689445A1 (fi)
JP (1) JPH08507775A (fi)
AU (1) AU6426994A (fi)
CA (1) CA2158437A1 (fi)
FI (1) FI954348A (fi)
PL (1) PL310821A1 (fi)
WO (1) WO1994021268A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4424675A1 (de) * 1994-07-13 1996-01-18 Bayer Ag Antacidazubereitung mit verbessertem Sicherheitsprofil
CA2477964A1 (en) * 2002-03-04 2003-09-12 Medrx Co., Ltd. Liquid matrix transforming its phase in living body and oral liquid preparation
JP6466906B2 (ja) 2013-03-15 2019-02-06 マリンクロット ホスピタル プロダクツ アイピー リミテッド パルス的および連続的流れ制御による治療用ガス送達装置
CN114917198B (zh) * 2022-06-22 2023-05-12 海南妙音春制药有限公司 一种铝碳酸镁咀嚼片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579634A (en) * 1968-04-18 1971-05-18 Garland Richard Brown Novel antacid compositions and methods for their administration
US3591680A (en) * 1969-11-17 1971-07-06 Smith Kline French Lab Concentrated antacid compositions and method of producing antacid activity
FR2153174B1 (fi) * 1971-09-23 1976-04-16 Biotherax Lab
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
FR2512344A1 (fr) * 1981-09-08 1983-03-11 Af Aplicaciones Far Lab Procede de fabrication d'une suspension stable d'hydroxyde d'alumine et/ou d'hydroxyde de magnesie comme agent actif des antacida
GB2201594B (en) * 1986-06-24 1991-02-13 Istvan Racz Production of acid binding pharmaceutical preparations
EP0484106A1 (en) * 1990-11-01 1992-05-06 Merck & Co. Inc. Controlled release formulations

Also Published As

Publication number Publication date
WO1994021268A1 (en) 1994-09-29
PL310821A1 (en) 1996-01-08
FI954348A (fi) 1995-11-15
CA2158437A1 (en) 1994-09-29
EP0689445A1 (en) 1996-01-03
FI954348A0 (fi) 1995-09-15
AU6426994A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
US6476006B2 (en) Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
EP0797435B1 (en) Controlled release matrix for pharmaceuticals
TWI592159B (zh) 藥學組成物
AU2001268719A1 (en) Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
KR101653690B1 (ko) 제산제로서 사용되는 혼합 금속 화합물
JPH10509180A (ja) 胃腸障害の処置用のファモチジンとスクラルファートの安定化組成物
JP3725542B2 (ja) ピコサルフェート剤形
HU201867B (en) Process for producing in water dispergatable tablets
JP2001512451A (ja) アモキシシリンおよびクラブラン酸塩を含む医薬処方
JP2002524412A (ja) 速放性錠剤
JPH04290816A (ja) 延長された胃の滞留時間を有する制酸調製物
CZ274497A3 (cs) Mukoadhesivní granule, způsob jejich výroby a farmaceutická kompozice s jejich obsahem
JPH0625064B2 (ja) 制御放出塩化カリウム
US5651984A (en) Controlled release potassium tablet
US4863743A (en) Controlled release potassium chloride
JPH10500412A (ja) カルシウム摂取を増加させるための方法および組成物
JPH08507775A (ja) 放出制御性のアルミニウム含有医薬製剤
EP1673064A1 (en) Pharmaceutical composition comprising anticonvulsant with taste mask coating
EP1004297B1 (en) Pharmaceutical compositions for oral administration containing a gastroresistant coating based on acrylic polymers
JP2001523704A (ja) α−グルコシダーゼ阻害剤を含んで成る持続放出性製剤
JP4224866B2 (ja) 溶解時間を制御した基剤
WO2005079753A2 (en) Extended release pharmaceutical compositions of divalproex sodium
US20020009474A1 (en) Method and composition for increasing calcium uptake
HUT75639A (en) Aluminium containing pharmaceutical preparation with controlled release and a process for its production
HU215442B (hu) Eljárás az alumínium felszívódását gátló, szabályozott hatóanyag-leadású, alumíniumtartalmú antacid és egyéb gyógyszerkészítmények előállítására